| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2008-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60031ebeaf6f302052aaedf8af63bd62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc9e519b7c6075f09cbeeda02e22b4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb64a152be2fd5ab49a34c26e784b2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a3669e10a25e64267f400af0e6fc317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c497a81890799f29df912b673461ed34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_579591167a9806742e1c55c9e3e08eeb |
| publicationDate |
2010-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010272732-A1 |
| titleOfInvention |
Emp2 antibodies and their therapeutic uses |
| abstract |
The present invention provides methods and compositions useful in the treatment or prevention of Chlamydia infections and cancer. The methods and compositions inhibit the entry of Chlamydia into a host cell expressing EMP2 by interfering with the interaction between the Chlamydia and EMP2. The methods and compositions target cancers which express or overexpress EMP2 nucleic acids and polypeptides by targeting EMP2. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015079089-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9464135-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013004493-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017096397-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103421742-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103421743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11053310-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013056248-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2812354-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2831110-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110545842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015508066-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015329621-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019213020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013148263-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013119693-A1 |
| priorityDate |
2005-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |